Navigation Links
Summit VetPharm Offers New Flea Topical Vectra for Dogs & Puppies(TM) For Long-Lasting Protection
Date:4/15/2009

Dinotefuran and Pyriproxyfen Combination Delivers Safe and Effective Control of All Stages of Fleas on Dogs

FORT LEE, N.J., April 15 /PRNewswire/ -- Summit VetPharm announces the introduction of Vectra for Dogs & Puppies(TM), a new monthly, topical, flea control product containing dinotefuran and pyriproxyfen in combination to deliver a complete single dose monthly applied product that protects your dog from all stages of fleas -- adults, eggs, larvae and pupae. Vectra for Dogs & Puppies(TM) is the newest product in the Vectra(R) line from Summit VetPharm which includes Vectra 3D(R), Vectra(R) for Cats & Kittens and Vectra for Cats(R). It can be used on dogs as young as eight weeks of age for year round flea treatment and prevention.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090415/NY99255 )

Vectra for Dogs & Puppies(TM):

  • Kills adult fleas; starts killing fleas within 2 hours
  • Provides ongoing protection against fleas and the diseases they may transmit, including tularemia, bartonellosis and rickettsiosis
  • Protects dogs from flea infestations that may cause anemia, tapeworm disease and flea allergy dermatitis (FAD)
  • Contains an IGR -- pyriproxyfen -- stable in sunlight, prevents development of all immature flea stages (eggs, larvae and pupae) for 1 month
  • Can be used on puppies as young as 8 weeks of age
  • Patented applicator provides convenient topical treatment

Vectra for Dogs & Puppies(TM) efficacy data confirms that it has one of the quickest onsets of killing activity of any topical flea product, while providing month-long protection against all stages of fleas (eggs, larvae, pupae and adult fleas). "In a study conducted to evaluate the duration of adulticide activity against fleas for Vectra(R) in dogs weighing 21-55 pounds, Vectra(R) began killing fleas within 2 hours following a single application and continued to perform for 30 days maintaining a 100% reduction in fleas throughout the duration of the study," explained Dr. Cathy Ball, Summit VetPharm Veterinary Services.

"Pet owners want fleas killed as quickly as possible to end their dog's suffering," says Dr. Ball. "Oftentimes, the successive feeding activity of fleas on dogs elicits a hypersensitivity skin disorder known as flea allergy dermatitis (FAD). Treatment of dogs with Vectra for Dogs & Puppies(TM) kills fleas and may reduce further evidence of FAD."

Pet owners and their dogs have a variety of lifestyles. Differing lifestyles, coupled with the differing parasites endemic to the area of the country, means their vector protection needs may be different. "Vectra for Dogs & Puppies(TM) is the perfect companion to Vectra 3D(R)," says Julia Stephanus, President and CEO of Summit VetPharm. "The Vectra for Dogs and Puppies(TM) is recommended for dogs whose lifestyles, size, breed and geography dictate the need for outstanding flea protection. Vectra 3D(R), our first commercial veterinary product, has a broader spectrum for those dogs whose lifestyle exposes them to fleas, ticks, mosquitoes, lice, mites and sand flies."

Vectra for Dogs & Puppies(TM) dual-action formula includes dinotefuran, a fast-acting, third generation neonicotinoid with a novel mode of action and pyriproxyfen, an insect growth regulator (IGR) that controls and prevents the development at all immature flea stages including eggs, larvae, and pupae. Tested with up to five times the recommended dose, Vectra(R) showed no significant adverse effects.

The unique, elongated, patented applicator tip makes Vectra for Dogs & Puppies(TM) easy to apply to a dog's skin through the hair coat. The rounded tip minimizes risk of skin abrasions. The easy-to-open applicator eliminates splash back and spilling, and the contoured shape makes it easier to handle and apply. With the one-piece applicator, there is no need to use scissors to open or remove a cap, making application fast and efficient, and at the same time, minimizing the potential of a choking hazard.

Summit VetPharm's Bloodhound(R) Technology -- an innovative, proprietary track and trace system, ensures veterinary exclusivity and authenticity of the product. Each package of Vectra(R) can be traced from the point of manufacture to the veterinary purchase. Bloodhound(R) Technology allows Summit VetPharm to maintain the integrity of its products through a secure distribution channel, as well as, guarding against counterfeits. "We are able to enhance the role of veterinarians in the lives of the animals they treat. Through our Bloodhound(R) Technology, we can help keep companion animal health in the hands of professionals," states Stephanus.

Vectra for Dogs & Puppies(TM), Vectra(R) for Cats & Kittens, Vectra for Cats(R) and Vectra 3D(R) are available to veterinarians through Summit VetPharm and Abbott Animal Health sales representatives, as well as from the following distributors: Henry Schein Animal Health, Midwest Veterinary Supply, Inc., Merritt Veterinary Supplies, Inc., NLS Animal Health, PCI Animal Health, Sanum Puerto Rico, Victor Medical Company and Webster Veterinary.

Summit VetPharm

Founded by veterinarians and experienced industry professionals, Summit VetPharm is committed to protecting the health and welfare of both companion animals and companion animal veterinary practices. Based in Fort Lee, New Jersey, Summit VetPharm is a wholly-owned subsidiary of the Sumitomo Corporation and part of the Sumitomo Corporation group of companies. For more information, visit Summit VetPharm at www.summitvetpharm.com.


'/>"/>
SOURCE Summit VetPharm
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. Education Key Focus of Michigan Policy Summit
4. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
5. DURECT to Present at Merriman Curhan Fords Annual Investor Summit
6. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
7. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
8. Historic Breast Cancer Global Advocate Summit Convenes in Budapest, Hungary on September 29-30
9. Summit on Spinal Muscular Atrophy
10. Global Leaders Converge for Special Olympics Global Policy Summit
11. Sanofi-aventis US Chairman Tim Rothwell Addresses CMSAs Collaborative Practice Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , ... May 27, 2016 , ... W.S. Badger ... announced today that it has been recognized as one of the best small businesses ... was named as one of nine small businesses providing progressive benefits to new parents ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... ... with Mediaplanet to help educate the many who are unaware of the plight ... to aphasia will run within the “Stroke Awareness” campaign. , The link between ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... in the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation ... providing proof of successfully certified products, services and staff. , Validation Center is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, ... members and suppliers for its inaugural Member Conference at the Paris Hotel in ... elevating the operational health of America’s healthcare providers. , The conference was highlighted ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia ... negative impact on long-term patient survival, reports a team of UPMC researchers in ... week in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... England , May 25, 2016 ... company employing the precision of circulating tumour DNA ... today announces the appointment of Professor Clive ... provide medical leadership across the clinical development programme, ... Inivata,s products help deliver significant improvements in clinical ...
Breaking Medicine Technology: